News
Aprea Therapeutics Announces Presentations On Its Next Generation WEE1 Inhibitor, APR-1051, And A Novel Macrocyclic ATR Inhibitor, ATRN-119, At AACR Annual Meeting 2024
10 Apr 24
Biotech, News, General
12 Health Care Stocks Moving In Thursday's Pre-Market Session
4 Apr 24
Movers
Wedbush Maintains Outperform on Aprea Therapeutics, Raises Price Target to $11
27 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Aprea Therapeutics, Maintains $20 Price Target
26 Mar 24
News, Price Target, Analyst Ratings
Aprea Therapeutics: Q4 Earnings Insights
26 Mar 24
Earnings
Why Is Precision Oncology-Focused Aprea Therapeutics Stock Trading Higher On Monday?
11 Mar 24
Biotech, Equities, News, Financing, FDA, Movers, Trading Ideas, General
12 Health Care Stocks Moving In Monday's Pre-Market Session
11 Mar 24
Movers
Market-Moving News for March 11th
11 Mar 24
Movers, Trading Ideas
Aprea Therapeutics Announces Private Placement Financing Of Up To $34M
11 Mar 24
News, Financing, Offerings
Aprea Therapeutics Announces FDA Clearance Of IND For APR-1051, Its Next Generation WEE1 Kinase Inhibitor For Cyclin E Overexpressing Cancers
11 Mar 24
Biotech, News, FDA, General
Aprea Therapeutics Announces Submission Of IND Application For APR-1051, A Next Generation WEE1 Kinase Inhibitor
6 Feb 24
Biotech, News, FDA, General
Press releases
Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024
10 Apr 24
News, Press Releases
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
26 Mar 24
Earnings, Press Releases
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
11 Mar 24
News, Financing, Press Releases
Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its Next Generation WEE1 Kinase Inhibitor for Cyclin E Overexpressing Cancers
11 Mar 24
Health Care, Press Releases
Aprea Therapeutics Announces Acceptance of Abstracts at American Association of Cancer Research Annual Meeting 2024
5 Mar 24
News, Press Releases
Aprea Therapeutics Announces Submission of IND Application for APR-1051, a Next Generation WEE1 Kinase Inhibitor
6 Feb 24
Health Care, Press Releases